Physician

Alexandru I Costea, M.D.

According to 2025 Medicare claims, Alexandru Costea, M.D. (NPI: 1972551190) practices cardiac electrophysiology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is THE CHRIST HOSPITAL CARDIOVASCULAR ASSOCIATES LLC (NPI: 1497901458; TIN: 263070266) and primary practice location at 45219-2906. Costea is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160), participating under the MSSP model.

Costea's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 471 traditional Medicare patients, billed 2,934 HCPCS/CPT codes, and received $253,142 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 910 prescription claims across 219 beneficiaries totaling $300,698 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 17 records totaling $48,334. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $95,266 to $253,142. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $63,820 to $300,698. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	536	1,550	$95,266
2016	472	1,530	$101,254
2017	441	1,406	$111,190
2018	834	2,054	$182,925
2019	896	2,373	$166,978
2020	863	2,503	$190,144
2021	811	2,603	$205,996
2022	819	2,542	$189,033
2023	612	2,151	$191,786
2024	471	2,934	$253,142

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	195	1,381	$63,820
2016	196	1,228	$77,961
2017	220	1,544	$135,262
2018	356	2,389	$305,804
2019	385	2,562	$451,767
2020	370	2,480	$553,406
2021	391	2,244	$629,912
2022	445	2,258	$763,892
2023	359	1,379	$524,577
2024	219	910	$300,698

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	144	144	$156
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	117	144	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	200	224	$89
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	122	341	$14
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	116	150	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	260	12,360	$237,384
Xarelto	Rivaroxaban	59	2,533	$45,501
Enoxaparin Sodium	Enoxaparin Sodium	30	404	$3,218
Amiodarone Hcl	Amiodarone Hcl	87	5,065	$3,153
Metoprolol Succinate	Metoprolol Succinate	147	10,602	$1,390

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$11,059	ABIOMED
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$37,275	Biosense Webster, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexandru I. Costea, M.D.?

Tedicare shows public-source Medicare data for Alexandru I. Costea, M.D. (NPI 1972551190), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexandru I. Costea, M.D. have ACO affiliation data?

Alexandru I. Costea, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160).

What billing organization is linked to Alexandru I. Costea, M.D.?

Alexandru I. Costea, M.D. is linked to THE CHRIST HOSPITAL CARDIOVASCULAR ASSOCIATES LLC (billing NPI 1497901458) in the available physician profile data.

Does Alexandru I. Costea, M.D. have Open Payments data?

Alexandru I. Costea, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.